Evaxion Biotech A/S (EVAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 30.57M |
| Enterprise Value | 14.84M |
| P/E Ratio | -0.53 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.72 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | -1.36 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.15 |
| Operating Margin | -1.16 |
AD
Management Effectiveness
| Return On Assets | -0.45 |
| Return On Equity | -0.61 |
Income Statement
| Revenue | 7.53M |
| Revenue/Share | 17.97 |
| Gross Profit | 7.53M |
| EBITDA | -7.12M |
| Net Income | -7.71M |
| Diluted EPS | -1.21 |
Balance Sheet
| Total Cash | 14M |
| Total Cash/Share | 33.57 |
| Total Debt | 7.1M |
| Total Debt/Equity | 0.75 |
| Current Ratio | 5.06 |
| Book Value Per Share | 22.86 |
Price History
| 52-Week Change | 5.9 |
| 52-Week High | 12.15 |
| 52-Week Low | 2.77 |
| Moving Average 50 Days | 3.08 |
| Moving Average 200 Days | 3.82 |
Statistics
| Average Volume | 199,323 |
| Shares Outstanding | 6.32M |
| % Held by Institutions | 381.81 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | January 14, 2025 |
AD
